Cannara Biotech Inc.
LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 84.70M | 81.39M | 79.97M | 76.57M | 72.88M |
| Total Other Revenue | 684.80K | 342.30K | 406.90K | 467.00K | 286.70K |
| Total Revenue | 85.38M | 81.73M | 80.38M | 77.03M | 73.17M |
| Cost of Revenue | 48.87M | 46.96M | 45.80M | 43.08M | 40.51M |
| Gross Profit | 36.51M | 34.77M | 34.58M | 33.95M | 32.66M |
| SG&A Expenses | 21.02M | 19.95M | 18.31M | 16.61M | 15.69M |
| Depreciation & Amortization | 1.12M | 1.10M | 1.11M | 1.13M | 925.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.90M | 68.78M | 65.81M | 61.33M | 57.68M |
| Operating Income | 13.48M | 12.95M | 14.57M | 15.71M | 15.49M |
| Income Before Tax | 11.83M | 10.96M | 12.20M | 12.94M | 12.40M |
| Income Tax Expenses | 3.93M | 3.63M | 3.77M | 3.59M | 1.26M |
| Earnings from Continuing Operations | 7.89 | 7.33 | 8.42 | 9.35 | 11.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.89M | 7.33M | 8.42M | 9.35M | 11.14M |
| EBIT | 13.48M | 12.95M | 14.57M | 15.71M | 15.49M |
| EBITDA | 18.19M | 17.37M | 19.17M | 20.30M | 19.75M |
| EPS Basic | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 |
| Normalized Basic EPS | 0.08 | 0.07 | 0.08 | 0.09 | 0.08 |
| EPS Diluted | 0.08 | 0.07 | 0.08 | 0.09 | 0.12 |
| Normalized Diluted EPS | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 |
| Average Basic Shares Outstanding | 380.30M | 372.95M | 367.15M | 363.45M | 362.03M |
| Average Diluted Shares Outstanding | 388.50M | 380.59M | 374.42M | 369.82M | 367.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |